Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.
| Revenue (TTM) | $2.36B |
| Gross Profit (TTM) | $236.52M |
| EBITDA | $56.94M |
| Operating Margin | 1.86% |
| Return on Equity | 4.31% |
| Return on Assets | 2.03% |
| Revenue/Share (TTM) | $19.01 |
| Book Value | $6.20 |
| Price-to-Book | 3.59 |
| Price-to-Sales (TTM) | 1.17 |
| EV/Revenue | 1.021 |
| EV/EBITDA | 42.27 |
| Quarterly Earnings Growth (YoY) | 250.00% |
| Quarterly Revenue Growth (YoY) | 21.40% |
| Shares Outstanding | $127.73M |
| Float | $115.42M |
| % Insiders | 6.18% |
| % Institutions | 98.29% |
Volatility is currently expanding
ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D.
Privia Health Group NASDAQ: PRVA reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following what Chief Executive Officer Parth Mehrotra described as strong first-half execution.
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.02 per share a year ago.
2Q'26 Net Income of $9.0M, +236.7% from 2Q'25 2Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25 Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six-month periods ended June 30, 2026.
Former CEO Shawn Morris sold 135,498 shares on June 30 and July 1, 2026, generating proceeds of ~$3.57 million at a weighted average price around $26.32 per share. Morris' sale reduced direct ownership to 76,651 shares post-transaction.
ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2026 before market open on Thursday, August 6, 2026.
Fort Lauderdale, May 28, 2026 (GLOBE NEWSWIRE) -- Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies,is pleased to announce it acted as the exclusive financial advisor to the Neurology Group of Bergen County (“NGBC”) in its partnership with Privia Health. Founded in 1973, the Neurology Group of Bergen County is one of the region's most respected independent neurology practices, serving the communities of Bergen County, New Jersey.
Investors looking for stocks in the Medical Info Systems sector might want to consider either TruBridge (TBRG) or Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PRVA and any ticker you trade — then tracks every position and per-strategy win rate.
